Artificial Intelligence for Response Assessment in Pediatric Neuro-Oncology (AI-RAPNO), part 2: challenges, opportunities, and recommendations for clinical translation | Synapse
March 3, 2026Open Access
Artificial Intelligence for Response Assessment in Pediatric Neuro-Oncology (AI-RAPNO), part 2: challenges, opportunities, and recommendations for clinical translation
Puntos clave
AI has the potential to enhance response assessment in pediatric neuro-oncology, addressing current limitations.
Clinical translation remains challenging due to varying data quality and the need for robust biomarkers.
Recommendations focus on improving data integration and developing standard protocols for implementation.
These insights may enable better treatment outcomes for children diagnosed with neuro-oncological conditions.